| Jul 26 |
(MIRA) - Analyzing Mira Pharmaceuticals's Short Interest
|
| Jul 25 |
Mental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical Data
|
| Jul 25 |
MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action
|
| Jul 24 |
We're Not Very Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Rate
|
| Jul 23 |
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
|
| Jul 22 |
S&P 500 Gains 1%; MIRA Pharmaceuticals Shares Spike Higher
|
| Jul 22 |
MIRA stock rallies 154% on preclinical results for ketamine drug
|
| Jul 22 |
Nano-Cap MIRA Pharmaceuticals' Oral Ketamine Analog Shows Potential In Neuropsychiatric Disorders
|
| Jul 22 |
Nasdaq Gains 1%; Chicago Fed National Activity Falls In June
|
| Jul 22 |
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
|
